These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 24084340)

  • 1. Pertussis immunisation and control in England and Wales, 1957 to 2012: a historical review.
    Amirthalingam G; Gupta S; Campbell H
    Euro Surveill; 2013 Sep; 18(38):. PubMed ID: 24084340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigating the pertussis resurgence in England and Wales, and options for future control.
    Choi YH; Campbell H; Amirthalingam G; van Hoek AJ; Miller E
    BMC Med; 2016 Sep; 14(1):121. PubMed ID: 27580649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Australian vaccine preventable disease epidemiological review series: pertussis, 2006-2012.
    Pillsbury A; Quinn HE; McIntyre PB
    Commun Dis Intell Q Rep; 2014 Sep; 38(3):E179-94. PubMed ID: 25391404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The epidemiology of pertussis in England and Wales.
    Miller E; Vurdien JE; White JM
    Commun Dis Rep CDR Rev; 1992 Dec; 2(13):R152-4. PubMed ID: 1285134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accelerating control of pertussis in England and Wales.
    Campbell H; Amirthalingam G; Andrews N; Fry NK; George RC; Harrison TG; Miller E
    Emerg Infect Dis; 2012 Jan; 18(1):38-47. PubMed ID: 22260989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Whole-Cell or Acellular Pertussis Primary Immunizations in Infancy Determines Adolescent Cellular Immune Profiles.
    van der Lee S; Hendrikx LH; Sanders EAM; Berbers GAM; Buisman AM
    Front Immunol; 2018; 9():51. PubMed ID: 29416544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pertussis in the Netherlands, is the current vaccination strategy sufficient to reduce disease burden in young infants?
    van der Maas NA; Mooi FR; de Greeff SC; Berbers GA; Spaendonck MA; de Melker HE
    Vaccine; 2013 Sep; 31(41):4541-7. PubMed ID: 23933365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Historical review of pertussis and the classical vaccine.
    Cherry JD
    J Infect Dis; 1996 Nov; 174 Suppl 3():S259-63. PubMed ID: 8896526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protocol for Pertussis Immunisation and Food Allergy (PIFA): a case-control study of the association between pertussis vaccination in infancy and the risk of IgE-mediated food allergy among Australian children.
    Estcourt MJ; Marsh JA; Campbell DE; Gold MS; Allen KJ; Richmond P; Waddington CS; Snelling TL
    BMJ Open; 2018 Jan; 8(1):e020232. PubMed ID: 29391374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The epidemiology of pertussis in Germany: past and present.
    Hellenbrand W; Beier D; Jensen E; Littmann M; Meyer C; Oppermann H; Wirsing von König CH; Reiter S
    BMC Infect Dis; 2009 Feb; 9():22. PubMed ID: 19243604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection against clinical pertussis induced by whole-cell pertussis vaccination is related to primo-immunisation intervals.
    Silfverdal SA; Ehlin A; Montgomery SM
    Vaccine; 2007 Oct; 25(43):7510-5. PubMed ID: 17905483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whooping cough—where are we now? A review.
    Kiedrzynski T; Bissielo A; Suryaprakash M; Bandaranayake D
    N Z Med J; 2015 Jun; 128(1416):21-7. PubMed ID: 26117672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating the impact of a continued maternal pertussis immunisation programme in England: A modelling study and cost-effectiveness analysis.
    Sandmann F; Jit M; Andrews N; Buckley HL; Campbell H; Ribeiro S; Sile B; Stowe J; Tessier E; Ramsay M; Amirthalingam G; Choi YH
    Vaccine; 2021 Jul; 39(32):4500-4509. PubMed ID: 34183204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Licensed pertussis vaccines in the United States. History and current state.
    Klein NP
    Hum Vaccin Immunother; 2014; 10(9):2684-90. PubMed ID: 25483496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategies to control pertussis in infants.
    Amirthalingam G
    Arch Dis Child; 2013 Jul; 98(7):552-5. PubMed ID: 23698594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of an accelerated immunisation schedule on pertussis in England and Wales.
    White JM; Fairley CK; Owen D; Matthews RC; Miller E
    Commun Dis Rep CDR Rev; 1996 May; 6(6):R86-91. PubMed ID: 8664929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age-specific effectiveness following each dose of acellular pertussis vaccine among infants and children in New Zealand.
    Radke S; Petousis-Harris H; Watson D; Gentles D; Turner N
    Vaccine; 2017 Jan; 35(1):177-183. PubMed ID: 27866766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole-cell or acellular pertussis vaccination in infancy determines IgG subclass profiles to DTaP booster vaccination.
    van der Lee S; Sanders EAM; Berbers GAM; Buisman AM
    Vaccine; 2018 Jan; 36(2):220-226. PubMed ID: 29199041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pertussis before and after the introduction of acellular pertussis vaccines in Finland.
    Elomaa A; He Q; Minh NN; Mertsola J
    Vaccine; 2009 Sep; 27(40):5443-9. PubMed ID: 19628060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pertussis continues to put New Zealand's immunisation strategy to the test.
    Grant CC; Reid S
    N Z Med J; 2010 Apr; 123(1313):46-61. PubMed ID: 20581895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.